Industry practice

Healthcare & Life Sciences Market Research & Consulting

The healthcare and life sciences practice covers pharmaceuticals, medical devices, diagnostics, biotechnology and healthcare services. Studies size markets bottom-up from procedure volumes, installed base and evidence-based pricing, and consulting engagements apply the same models to entry, pricing and due diligence decisions.

Book a Consultation Browse the reports

Fixed fee engagements Bottom-up sector models 2025 base year, 2035 horizon

Coverage

What the Healthcare & Life Sciences practice covers

Demand in this sector moves with procedure counts, reimbursement policy, regulatory approvals and the replacement cycles of installed equipment, so every model in the practice is built on those drivers rather than on top-down spend figures. Regulatory context from the FDA, EMA and major Asian agencies is tracked as part of the standard scope.

PharmaceuticalsMedical devicesIn-vitro diagnosticsBiotechnologyHospital and lab servicesDigital health

One methodology, every sector

Sector studies follow the published Douglas Insights methodology: bottom-up models, numbered sources and confidence grades on every figure.

Read the methodology →

Sector consulting

Consulting for Healthcare & Life Sciences

Sector consulting draws on the same models that power the reports: market entry for devices and diagnostics, launch pricing against reimbursement realities, competitive intelligence on manufacturers, and commercial due diligence for healthcare deals.

All consulting services →

Market Sizing & Opportunity Assessment

TAM, SAM and SOM built bottom-up, with the working model included in the deliverable.

Competitive Intelligence & Benchmarking

Competitor profiling, financial tracking, win/loss analysis and pricing audits on a defensible evidence base.

Go-To-Market Strategy

Segment targeting, positioning, channel design and launch roadmaps grounded in sized demand.

Customer & Consumer Intelligence

Voice of customer, segmentation, satisfaction tracking and brand studies run by analysts, not panels alone.

Pricing & Monetization Strategy

Value-based pricing, elasticity research and packaging design that protects margin.

M&A & Commercial Due Diligence

Market due diligence for investors and acquirers: demand, competition and growth tested under deal timelines.

Regulatory & Value Chain Advisory

Compliance mapping, supply chain studies and sourcing strategy for regulated and trade-exposed markets.

Data & Analytics Solutions

Data as a service, installed base modelling and decision dashboards built on our market models.

Data products

Drug pipeline data for Healthcare & Life Sciences

Drug pipeline

Drug pipeline reviews by therapy area

Every drug candidate in clinical development for a therapy area, counted by phase from registered trials and reviewed by the research desk, with sponsors, readouts and a 40–50 page review.

Candidates by phase and sponsor
Readout calendar
Excel tracker of every asset

See drug pipelines →160 therapy areas

Answers at a glance

Questions the Healthcare & Life Sciences practice answers

How are healthcare markets sized differently?

Healthcare markets are sized from clinical activity: procedure volumes, diagnostic test counts and installed equipment, multiplied by tender-evidenced prices. Top-down healthcare spend figures are used only as a cross-check, never as the build.

Do studies account for reimbursement?

Yes. Reimbursement and tender dynamics set realistic price trajectories in every forecast, because in most healthcare markets the payer, not the end user, decides what a product earns.

Can you support a medical device market entry?

Yes. Entry engagements combine market sizing, regulatory pathway mapping and channel economics for the target geographies, delivered as a fixed fee project with the working model included.

Segments

Healthcare & Life Sciences segment coverage

Syndicated research

Healthcare & Life Sciences market research reports

All reports →

DI-HC-10113 Healthcare & Life Sciences Veterinary Diagnostic Imaging Equipment Market